IMTM GmbH - Company Review
IMTM GmbH - Company ReviewSummary
IMTM GmbH (IMTM) is a developer of pharmaceutical products for inflammatory diseases and provides preclinical services to the pharmaceutical industry. The company’s services include pharmaceutical development and experimental and clinical medicine. Its therapeutic concepts are targeted to peptidase-based immunmodulation and thiol-based cytoprotection. IMTM offers a set of in silico, in vivo and in vitro methods for discovery, optimization and assessment of drug candidates up to clinical trials. The company provides development and research facility in the field of immunology and internal medicine. IMTM is headquartered in Magdeburg, Germany.
This comprehensive company report of IMTM GmbH provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.